AAPG Stock: Price, Earnings History and SEC Filings
Ascentage Pharma Group Internat (AAPG) last traded at $14.46, down 2.84% on the latest session and down 11.4% over the past month.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
AAPG earnings history
Earnings history is not available right now.
Latest SEC filings for AAPG
Insider filing activity
AAPG insiders filed 0 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
AAPG news
- William Blair Expands Biotech Research as Veteran Analyst Alethia Young Initiates CoverageOct 21, 2026 · finance.yahoo.com
- Ascentage Pharma’s Lisaftoclax Granted Breakthrough Therapy Designation in China for Treatment-Naïve CLL/SLLOct 20, 2026 · finance.yahoo.com
- Ascentage Pharma (SEHK:6855) Stock Looks Above Fair Value After The FallOct 19, 2026 · finance.yahoo.com
About Ascentage Pharma Group Internat
Ascentage Pharma Group Internat (AAPG) is a US-listed public company on Nasdaq. The SEC classifies its business as Pharmaceutical Preparations. It is incorporated in Cayman Islands. Its fiscal year ends in December.